KOL directory

Five physician and scientific KOL candidates per asset for physician-led equity and advisory roles. Profile links open third-party sources.

Five KOL candidates per RI patent asset or company, identified via patent inventors, publication co-authors, trial/clinical program pages, company SAB/advisory lists, and web search (June 2026). physician_led_fit reflects suitability for equity + formal KOL advisory per ri_physician_led_financing.json—not a recommendation to contact without COI review.

ip_wireless_neurograinsBrown OTL spinout (TBD)
  • 1. Leigh R. HochbergMD PhDhigh

    Brown Engineering; MGH; VA Providence CfNN

    BrainGate PI; neurocritical care; trial design

    Source
  • 2. Stephen T. MernoffMDhigh

    VA Providence; Brown Neurology

    VA BrainGate site PI; ALS/TBI clinics

    Source
  • 3. David BortonPhDscientific only

    Brown Engineering; RIH Neurosurgery affiliate

    Scientific PI; neurograins inventor

    Source
  • 4. Ziya GokaslanMDmedium

    Brown Health; Neurosurgeon-in-Chief RIH/Miriam

    Neurosurgery executive; implant program scale

    Source
  • 5. Theresa L. WilliamsonMDmedium

    Brown Health; CINNR / Norman Prince Spine

    CINNR director; SCI/neurotech clinical

    Source
ip_speech_tablet_ibciBrainGate / decode SPV
  • 1. Leigh R. HochbergMD PhDhigh

    BrainGate; Brown; VA Providence

    Sponsor-investigator; speech/tablet trials

    Source
  • 2. Stephen T. MernoffMDhigh

    VA Providence BrainGate site

    ALS typing trials; VA enrollment

    Source
  • 3. Stephen SallowayMD MSmedium

    Butler Hospital; Brown

    RI neurology; cognitive endpoints

    Source
  • 4. John SimeralPhDscientific only

    Brown; VA CfNN

    Decode algorithm co-inventor

    Source
  • 5. David BrandmanMD PhD FRCSCmedium

    UC Davis (BrainGate consortium)

    Speech neuroprosthesis surgeon co-author

    Source
ip_nanopieces_rnaNanoDe Therapeutics
  • 1. Richard TerekMDhigh

    Lifespan Cancer Institute; Brown Ortho Surgery

    Orthopedic oncology; Nanopieces co-author

    Source
  • 2. Alan H. DanielsMDhigh

    Brown Health Orthopedics; Spine Division Chief

    Ortho spine; joint/cartilage delivery KOL

    Source
  • 3. Qian ChenPhDscientific only

    RIH/Brown Ortho Research; NanoDe scientific founder

    Scientific founder; head SAB

    Source
  • 4. Bassel G. DieboMDmedium

    Brown Health; Spine Center Miriam

    Spine deformity; procedural KOL for ortho pilots

    Source
  • 5. Adetokunbo OyeleseMD PhD FAANSmedium

    Norman Prince Spine Institute; Brown Neurosurgery

    Neurosurgery spine director; CNS delivery angle

    Source
ip_chitinase_ocf203Ocean Biomedical / Elkurt / RI newco
  • 1. Jack A. EliasMDhigh

    Brown University; Dean Alpert Medical School

    Scientific founder; CHIT1 biology

    Source
  • 2. Rachel PutmanMD MPHhigh

    Brown Health; ILD Director

    ILD trial design; CALC site PI

    Source
  • 3. Barry S. SheaMDhigh

    MGH (ex-RIH ILD founder); Brown affiliate history

    IPF trial PI experience; Elias collaborator

    Source
  • 4. Corey E. VentetuoloMD MSmedium

    Brown Health; CALC Director

    Advanced lung disease; multisystem enrollment

    Source
  • 5. Caitlin SarmanianMDmedium

    Brown Health; Center for Advanced Lung Care

    ILD clinic; patient stratification

    Source
ip_ecm_morsels_xmXM Therapeutics Inc
  • 1. Frank W. SellkeMDhigh

    Brown University Health CV Research; ex-Chief CT Surgery RIH

    Cardiac surgery KOL; MI model translation

    Source
  • 2. Mark J. CunninghamMDhigh

    Brown Health; Chief Cardiovascular Surgery RIH

    Active cardiac surgery chief; HF/structural heart

    Source
  • 3. Rachel PutmanMD MPHhigh

    Brown Health; ILD Program Director

    ILD clinical lead if IPF indication pursued

    Source
  • 4. Corey E. VentetuoloMD MSmedium

    Brown Health; CALC Director

    Advanced lung disease; PH/ILD trials

    Source
  • 5. Jeffrey R. MorganPhDscientific only

    Brown; XM Therapeutics co-founder

    Scientific co-founder (not MD); SAB chair candidate

    Source
ip_iaip_neonatalProThera Biologics
  • 1. Yow-Pin LimMD PhDhigh

    ProThera Biologics; Brown Alpert

    Founder-scientist; physician equity archetype

    Source
  • 2. James F. PadburyMDhigh

    Women & Infants Hospital; Brown Alpert

    Pediatrician-in-Chief; NICU PI on SBIR LFIA

    Source
  • 3. Barbara S. StonestreetMDhigh

    Women & Infants Hospital; Brown Alpert

    Neonatal-perinatal; HIE/NEC SBIR collaborator

    Source
  • 4. Adam C. LevineMD MPH FACEPmedium

    Brown Emergency Medicine; RIH

    Pediatric sepsis digital health; complementary Dx pathway

    Source
  • 5. Stephanie C. GarbernMDmedium

    Brown Emergency Medicine; RIH

    mPI pediatric sepsis wearable study with Levine

    Source
ip_osteopearl_vcf_lenossLenoss Medical Inc
  • 1. Joseph LaneMDhigh

    Lenoss Medical Advisors

    Orthopedic surgery; OsteoPearl advisory

    Source
  • 2. J. Kevin McGrawMDhigh

    Lenoss Medical Advisors

    Interventional radiology; VCF procedures

    Source
  • 3. Michael SichlauMDhigh

    Lenoss Medical Advisors

    Interventional radiology

    Source
  • 4. Alan H. DanielsMDmedium

    Brown Health Ortho Spine

    RI spine surgeon; registry/KOL recruit

    Source
  • 5. Bassel G. DieboMDmedium

    Brown Health Spine Center

    Spine deformity; VCF referral network

    Source
ip_dendritic_ad_mindimmuneMindImmune Therapeutics
  • 1. Peter J. SnyderPhDmedium

    URI; MindImmune Consulting CMO

    Consulting CMO; AD biomarkers (not MD)

    Source
  • 2. M. Teresa Gomez-IslaMDhigh

    Harvard/MGH; MindImmune SAB

    Neurology; MADRC; AD clinical KOL

    Source
  • 3. Stephen SallowayMD MShigh

    Butler Hospital MAP; Brown Neurology/Psychiatry

    RI AD trial leader; prevention trials

    Source
  • 4. Ole IsacsonMDmedium

    McLean/Harvard; MindImmune SAB

    Neuroregeneration; innate immunity CNS

    Source
  • 5. Cynthia LemerePhDscientific only

    Brigham; MindImmune SAB

    Neurology research; immunology (PhD)

    Source
ip_spinal_isi_dbsBrown OTL / medtech SPV
  • 1. David BortonPhDscientific only

    Brown; RIH Neurosurgery; VA CfNN

    ISI PI; NCT04302259

    Source
  • 2. Jared FridleyMDhigh

    UT Austin (formerly RIH NPSI)

    ISI clinical neurosurgeon; DARPA demo

    Source
  • 3. Theresa L. WilliamsonMDhigh

    Brown Health; CINNR

    SCI rehab clinical leadership

    Source
  • 4. Stephen T. MernoffMDmedium

    VA Providence

    SCI/ALS rehab; VA neurotech

    Source
  • 5. Adetokunbo OyeleseMD PhD FAANSmedium

    Norman Prince Spine Institute

    Spine surgery; implant referral pathway

    Source
ip_tregitope_immunomodEpiVax Inc / EpiVax Therapeutics
  • 1. Anne S. De GrootMDhigh

    EpiVax founder; URI/UGA adjunct

    Physician-founder; immunoinformatics KOL

    Source
  • 2. Eleanor RamosMDmedium

    EpiVax Therapeutics advisors

    Clinical development; medical affairs

    Source
  • 3. Amy RosenbergMDmedium

    EpiVax; ex-FDA CDER

    Regulatory KOL; therapeutic spinout

    Source
  • 4. Judy LiebermanMD PhDmedium

    Harvard Medical School

    Immunology SAB; epitope biology

    Source
  • 5. Gary SteinbergMDmedium

    EpiVax Therapeutics (CMO pending)

    Oncology CMO for spinout therapeutics

    Source
ip_biglycan_mskBRF OTL newco (TBD)
  • 1. Justin R. FallonPhDscientific only

    Brown Neuroscience; Tivorsan founder

    Scientific founder; TVN-102/biglycan

    Source
  • 2. Kara A. StavrosMDhigh

    Brown Health; MDA Clinical Care Center RIH

    Neuromuscular clinic; DMD patient access

    Source
  • 3. Duyu A. NieMD PhDmedium

    Hasbro Children's; Brown Pediatric Neurology

    Pediatric neurology; neuromuscular disorders

    Source
  • 4. James F. PadburyMDmedium

    Women & Infants; Brown

    Perinatal/neonatal muscle-adjacent KOL (RI anchor)

    Source
  • 5. Barbara S. StonestreetMDmedium

    Women & Infants; Brown

    Neonatal HIE; RI clinical trial sites

    Source
ip_neural_decoding_legacyBrainGate / royalty
  • 1. Leigh R. HochbergMD PhDhigh

    BrainGate consortium

    Consortium clinical lead; FOU licenses

    Source
  • 2. Stephen T. MernoffMDhigh

    VA Providence

    VA site governance

    Source
  • 3. John DonoghuePhDscientific only

    Brown

    Legacy patent inventor; scientific

    Source
  • 4. Stephen SallowayMD MSmedium

    Butler/Brown

    RI clinical research network

    Source
  • 5. John SimeralPhDscientific only

    Brown; VA

    Decode co-inventor

    Source
ip_af_mapping_aiVolta Medical Inc
  • 1. Jerome KalifaMD PhDhigh

    Volta Medical; Brown faculty; RIH

    Co-founder CMO; VX1 clinical champion

    Source
  • 2. Corey E. VentetuoloMD MSmedium

    Brown Health CALC

    Cardiopulmonary; AF comorbidity trials

    Source
  • 3. Mark J. CunninghamMDmedium

    Brown Health Cardiac Surgery

    Structural heart surgical perspective

    Source
  • 4. Frank W. SellkeMDmedium

    Brown Health CV Research

    Cardiac surgery research emeritus leader

    Source
  • 5. Kaushik MandalMD MS MPHmedium

    Brown Health; Minimally invasive valve

    EP/valve quality outcomes

    Source
ip_genomics_hansNabsys 2.0 LLC
  • 1. Barrett BreadyMDhigh

    Nabsys CEO; Brown adjunct

    Physician-founder; OhmX commercial

    Source
  • 2. Karl T. KelseyMDmedium

    Brown Epidemiology/Pathology

    Cancer epigenomics; SV biomarker research

    Source
  • 3. Wafik S. El-DeiryMD PhDmedium

    Brown/Lifespan Cancer

    Precision oncology; tumor genomics

    Source
  • 4. Lucas A. SalasMD MPH PhDmedium

    Dartmouth (Brown collaborator)

    HiTIMED-adjacent epigenomic deconvolution

    Source
  • 5. Brock C. ChristensenPhDscientific only

    Brown Epidemiology

    Scientific anchor (not MD)

    Source
ip_ect_ophthalmologyNeurotech Pharmaceuticals
  • 1. Gaurav GuptaMDhigh

    Rhode Island Eye Institute; Brown Clinical Assoc Prof

    Vitreoretinal surgeon; implant procedures

    Source
  • 2. Peter J. McDonnellMDmedium

    Johns Hopkins Wilmer (Neurotech board 2026)

    National retina KOL; board governance

    Source
  • 3. Magdalena KrzystolikMDmedium

    Mass Eye and Ear; Providence service

    Retina specialist; MacTel expertise

    Source
  • 4. Stephen SallowayMD MSlow

    Butler/Brown

    Neurodegeneration trials network (adjacent)

    Source
  • 5. Barrett BreadyMDlow

    Nabsys; Brown

    RI physician-entrepreneur; genomics-adjacent

    Source
ip_monaghan_deep_rna_dxRIH deep RNA Dx spinout (forming)
  • 1. Sean F. MonaghanMD FACShigh

    RIH / Brown Surgery; Monaghan Lab

    Physician-founder; deep RNA-seq sepsis PI

    SourceSource
  • 2. Gerard J. NauPhDscientific only

    Brown / RIH surgical research

    Co-inventor; translational microbiology

    Source
  • 3. Alger M. FredericksPhDscientific only

    Monaghan Lab; Brown

    Co-inventor; RNA-seq methods (Sci Rep 2022)

    Source
  • 4. William G. FairbrotherPhDmedium

    Brown; splicing/NMD collaborator

    SAB; Whippet/NMD pipeline co-author

    Source
  • 5. Mitchell M. LevyMDhigh

    Brown / RIH critical care

    Sepsis clinical trials; Surviving Sepsis network

    Source
ip_bolden_musk_neurogenesisBolden Therapeutics Inc
  • 1. Stephen SallowayMD MShigh

    Butler Hospital; Brown ADRC

    Bolden scientific advisor; AD trials

    Source
  • 2. Justin R. FallonPhDscientific only

    Brown; Bolden SAB chair

    MuSK-BMP scientific founder

    Source
  • 3. Ashley E. WebbPhDscientific only

    Brown; Bolden co-founder

    Neural stem cell biology

    Source
  • 4. Johnny PageMD (trainee)medium

    Bolden CEO; Brown PLME

    Entrepreneur CEO; Fallon lab alum

    Source
  • 5. Peter J. SnyderPhDlow

    URI; AD biomarkers

    AD clinical trial design (adjacent KOL)

    Source
ip_pax_aav_vegf_tendonPax Therapeutics
  • 1. Paul Y. LiuMD FACShigh

    Brown Plastic Surgery; RIH; Pax chairman

    Physician-founder; hand/ortho KOL

    Source
  • 2. Jin Bo TangMDhigh

    Pax advisor; elite flexor tendon outcomes

    Hand surgery KOL

    Source
  • 3. Dom Messerli—low

    Lenoss CEO; RI ortho ecosystem

    MSK entrepreneur peer (not MD)

    Source
  • 4. Qian ChenPhDscientific only

    RIH/Brown; NanoDe

    Orthopedic delivery peer

    Source
  • 5. Xiao WuPhDscientific only

    Brown; AAV2-VEGF developer

    Scientific co-inventor

    Source
ip_oncolux_lumisOncoLux Inc
  • 1. Howard P. SafranMDhigh

    Brown Health Cancer Institute

    Surgical oncology trials network

    Source
  • 2. Wafik S. El-DeiryMD PhDmedium

    Legorreta Cancer Center

    Oncology translational advisor pool

    Source
  • 3. Rachel PutmanMD MPHmedium

    Brown Health ILD Program

    Thoracic/oncology adjacent (bronchoscopy path)

    Source
  • 4. Alan Kersey—scientific only

    OncoLux CEO

    Photonics founder (not MD)

    Source
  • 5. Mark A. TurcoMDmedium

    RI Life Science Hub CEO

    State ecosystem; cardiologist-operator

    Source
gap_smurf2_oncologySMURF-Therapeutics Inc
  • 1. Wafik S. El-DeiryMD PhD FACPhigh

    SMURF-Tx founder; Legorreta Cancer Center

    Founder; HIF/oncology KOL

    Source
  • 2. Howard SafranMDhigh

    Lifespan Cancer Institute; Brown

    Chief Hem/Onc; BU Oncology Group director

    Source
  • 3. Lucas A. SalasMD MPH PhDmedium

    Dartmouth; Brown collaborator

    Epigenetic biomarker trials

    Source
  • 4. Karl T. KelseyMDmedium

    Brown

    Cancer molecular epi; biomarker endpoints

    Source
  • 5. Stephen SallowayMD MSlow

    Butler/Brown

    WIN-adjacent RI oncology trials network

    Source
gap_soma_dtxSOMAScience (forming)
  • 1. Justin Y. LiMDhigh

    Norman Prince Spine Institute; Brown Neurosurgery

    Pain medicine; neuromodulation research

    Source
  • 2. Ross E. BarkerDOhigh

    Norman Prince Spine Institute; Brown

    Pain management; chronic pain clinic

    Source
  • 3. Laert RushaMDhigh

    Norman Prince Spine Institute

    Pain medicine; procedural pain

    Source
  • 4. Alexios G. CarayannopoulosDO MPHhigh

    Brown Health PM&R Chief

    PM&R pain; rehab integration for DTx

    Source
  • 5. Frederike H. PetzschnerPhDscientific only

    Brown Carney; SOMA PI

    Scientific founder (not MD); digital KOL

    Source
gap_christensen_epigeneticsHiTIMED diagnostics / pharma license (Dartmouth IP)
  • 1. Lucas A. SalasMD MPH PhDhigh

    Dartmouth; HiTIMED developer

    HiTIMED clinical translation; IO stratification

    Source
  • 2. Karl T. KelseyMDhigh

    Brown Epidemiology/Pathology

    Immunomethylomics; cancer epi

    Source
  • 3. Wafik S. El-DeiryMD PhDmedium

    Lifespan/Brown Cancer

    Precision oncology; pharma stratification deals

    Source
  • 4. Howard P. SafranMDmedium

    Brown Health Cancer Institute; Chief Hem/Onc

    Oncology trial PI; BU Oncology Group

    Source
  • 5. Brock C. ChristensenPhDscientific only

    Brown Epidemiology

    Scientific founder (not MD)

    Source
gap_ni2o_kiwi_bcini2o Inc
  • 1. Leigh HochbergMD PhDhigh

    Brown; BrainGate

    iBCI clinical trials; FTO diligence

    Source
  • 2. David BortonPhDscientific only

    Brown Engineering; RIH

    Implantable neurotech PI

    Source
  • 3. Newton HowardPhDscientific only

    ni2o CEO; Oxford/MIT

    BCI scientific founder

    Source
  • 4. Stevin H. ZornPhDlow

    MindImmune CSO

    Neurodegeneration therapeutics peer

    Source
  • 5. John DonoghuePhDscientific only

    Brown

    Legacy BMI patents; scientific

    Source
gap_levine_pediatric_sepsisBrown / RIH pediatric sepsis CDSS
  • 1. Adam C. LevineMD MPH FACEPhigh

    Brown EM; RIH

    PI wearable pediatric sepsis ML

    Source
  • 2. Stephanie C. GarbernMDhigh

    Brown EM; RIH

    mPI pediatric sepsis wearable

    Source
  • 3. Sean F. MonaghanMD FACSmedium

    RIH Surgery

    Complementary RNA Dx (orthogonal)

    Source
  • 4. Yow-Pin LimMD PhDmedium

    ProThera

    Neonatal sepsis biologic peer

    Source
  • 5. Mitchell M. LevyMDhigh

    Brown critical care

    Sepsis guidelines network

    Source
gap_uri_phlip_lnpURI PHLIP platform (spinout forming)
  • 1. Wafik S. El-DeiryMD PhDmedium

    Brown/Lifespan

    STING-oncology trial design peer

    Source
  • 2. Howard P. SafranMDmedium

    Brown Health Cancer

    Oncology translational

    Source
  • 3. Qian ChenPhDscientific only

    RIH; NanoDe

    RNA delivery peer (distinct chemistry)

    Source
  • 4. Karl T. KelseyMDmedium

    Brown

    Cancer biomarker trials

    Source
  • 5. Peter J. SnyderPhDlow

    URI

    RI research leadership adjacent

    Source
gap_rih_salivary_ev_adRIH salivary EV AD Dx
  • 1. Stephen SallowayMD MShigh

    Butler/Brown ADRC

    AD trial network

    Source
  • 2. Stevin H. ZornPhDlow

    MindImmune

    AD therapeutic peer

    Source
  • 3. Peter J. SnyderPhDmedium

    URI/Brown network

    AD biomarker expertise

    Source
  • 4. Sean F. MonaghanMD FACSmedium

    RIH

    Hospital translational PI peer

    Source
  • 5. Rachel PutmanMD MPHlow

    Brown Health

    Pulmonary/neuro adjacent

    Source
gap_rih_bx912_pulmonary_htnRIH BX-912 PH program
  • 1. Rachel PutmanMD MPHhigh

    Brown Health ILD/PH

    Pulmonary hypertension clinical

    Source
  • 2. Jack A. EliasMDmedium

    Brown

    Pulmonary medicine leadership

    Source
  • 3. Frank W. SellkeMDmedium

    Brown Health CV

    Cardiac surgery / vascular

    Source
  • 4. Mitchell M. LevyMDmedium

    Brown

    Critical care cardiopulmonary

    Source
  • 5. Howard P. SafranMDlow

    Brown Health

    Oncology-cardio interface

    Source
gap_rih_pahtn_dxRIH PAH/SCD diagnostics
  • 1. Rachel PutmanMD MPHhigh

    Brown Health

    PH/ILD diagnostics adoption

    Source
  • 2. Frank W. SellkeMDhigh

    Brown Health CV

    Cardiac risk / SCD

    Source
  • 3. Mark A. TurcoMDmedium

    RI Life Science Hub

    State clinical network

    Source
  • 4. Mitchell M. LevyMDmedium

    Brown

    ICU risk tools

    Source
  • 5. Jack A. EliasMDmedium

    Brown

    Pulmonary research

    Source
gap_rih_bbb_nucleic_deliveryRIH BBB nucleic acid delivery
  • 1. Stephen SallowayMD MShigh

    Brown ADRC

    CNS trial design

    Source
  • 2. Leigh HochbergMD PhDmedium

    Brown BrainGate

    CNS intervention peer

    Source
  • 3. Stevin H. ZornPhDlow

    MindImmune

    CNS therapeutic peer

    Source
  • 4. Justin R. FallonPhDscientific only

    Brown

    Neuroscience translation

    Source
  • 5. David BortonPhDscientific only

    Brown

    Neural engineering

    Source
gap_rih_motile_cell_mskRIH motile cell MSK repair
  • 1. Paul Y. LiuMD FACShigh

    Brown; Pax

    Hand/MSK surgery KOL

    Source
  • 2. Jin Bo TangMDhigh

    Pax advisor

    Tendon outcomes KOL

    Source
  • 3. Dom Messerli—low

    Lenoss

    Spine/ortho entrepreneur peer

    Source
  • 4. Jeffrey R. MorganPhDscientific only

    Brown/XM

    Matrix biology peer

    Source
  • 5. Jack A. EliasMDlow

    Brown

    Translational medicine

    Source
gap_rih_ecm_joint_repairRIH ECM joint repair
  • 1. Paul Y. LiuMD FACShigh

    Brown Surgery

    Joint/tendon clinical KOL

    Source
  • 2. Jeffrey R. MorganPhDscientific only

    Brown/XM

    ECM platform peer—FOU diligence

    Source
  • 3. Jin Bo TangMDhigh

    Hand surgery

    Orthopedic clinical outcomes

    Source
  • 4. Dom Messerli—low

    Lenoss

    Spine MSK devices

    Source
  • 5. Qian ChenPhDscientific only

    NanoDe

    Delivery/materials peer

    Source
gap_rih_enhancer_rna_gliomaRIH eRNA glioma therapeutics
  • 1. Howard P. SafranMDhigh

    Brown Health Cancer

    Neuro-oncology trials

    Source
  • 2. Wafik S. El-DeiryMD PhDmedium

    Lifespan/Brown

    Oncology translational

    Source
  • 3. Stephen SallowayMD MSmedium

    Brown

    CNS trial network

    Source
  • 4. Lucas A. SalasMD MPH PhDmedium

    Dartmouth

    Brain tumor epi peer

    Source
  • 5. Alan Kersey—low

    OncoLux

    Surgical oncology imaging peer

    Source
gap_rih_lpa_therapeuticRIH Lp(a) therapeutics
  • 1. Frank W. SellkeMDhigh

    Brown Health CV

    Cardiovascular outcomes KOL

    Source
  • 2. Mark A. TurcoMDmedium

    RI Life Science Hub

    Cardio metabolic network

    Source
  • 3. Jack A. EliasMDmedium

    Brown

    Pulmonary-vascular interface

    Source
  • 4. Mitchell M. LevyMDmedium

    Brown

    Critical care cardiology

    Source
  • 5. Howard P. SafranMDlow

    Brown Health

    Clinical trials infrastructure

    Source
Research synthesis from public sources (NIH RePORTER, ClinicalTrials.gov, PubMed, USPTO, company press). Not investment advice, legal opinion, or clinical guidance. Verify cap tables, license chains, and trial status in data rooms before term sheets.